Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Michelle L. Boland, Denise Oró, K.S. Tølbøl, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 33, pp. 4904-4920
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 189
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 107
Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
Bridget S. Gosis, Shogo Wada, Chelsea Thorsheim, et al.
Science (2022) Vol. 376, Iss. 6590
Open Access | Times Cited: 101
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Nature Metabolism (2024) Vol. 6, Iss. 6, pp. 1178-1196
Open Access | Times Cited: 63
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 55
Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol
James M. Eng, Jennifer L. Estall
Cells (2021) Vol. 10, Iss. 7, pp. 1805-1805
Open Access | Times Cited: 100
PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease
Maria E. Moreno‐Fernandez, Daniel A. Giles, Jarren R. Oates, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1187-1204.e9
Open Access | Times Cited: 95
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, et al.
BMC Gastroenterology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 94
Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
Christina‐Maria Flessa, Narjes Nasiri‐Ansari, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15791-15791
Open Access | Times Cited: 65
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH
Mathias B. Møllerhøj, Sanne Skovgård Veidal, Kirstine Tølbøl Thrane, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 5, pp. 1167-1186
Open Access | Times Cited: 46
Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
Panu K. Luukkonen, Ikki Sakuma, Rafael Calais Gaspar, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 35
Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner
Xiaojing Wang, Liangjing Wang, Lin Geng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5843-5843
Open Access | Times Cited: 27
Complement 3a receptor 1 on macrophages and Kupffer cells is not required for the pathogenesis of metabolic dysfunction-associated steatotic liver disease
Edwin A. Homan, Ankit Gilani, Alfonso Rubio‐Navarro, et al.
eLife (2025) Vol. 13
Open Access | Times Cited: 1
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
Yvonne Oligschlaeger, Ronit Shiri‐Sverdlov
Biomedicines (2020) Vol. 8, Iss. 2, pp. 28-28
Open Access | Times Cited: 55
Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
Li Hu, Qingling Wang, Peizhan Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 54
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
Emma L. Shepherd, Raquel Saborano, Ellie Northall, et al.
JHEP Reports (2020) Vol. 3, Iss. 2, pp. 100217-100217
Open Access | Times Cited: 50
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
John J. Nestor, David G. Parkes, Michael Feigh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice
Samuel M. Lee, Jose Muratalla, Saman Karimi, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 20
Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Randall H. Friedline, Hye Lim Noh, Sujin Suk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes
Amanda K. Jones, Besnik Bajrami, Morgan K. Campbell, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 6
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice
Kripa Shankar, Nathan P. Metzger, Connor Lawrence, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101950-101950
Open Access | Times Cited: 6
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Helene M. Ægidius, Sanne Skovgård Veidal, Michael Feigh, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
Fangli Zhou, Xiaoli Sun
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 39
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
Michiko Itoh, Atsushi Tamura, S KANAI, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 11
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top